首页 | 本学科首页   官方微博 | 高级检索  
检索        

药敏指导下的晚期乳腺癌化疗
引用本文:宁连胜,侯子正,李丽庆,毛慧生,孙慧,赵文华,王文治,韩来声,赵宝林,张天泽.药敏指导下的晚期乳腺癌化疗[J].中国肿瘤临床,1991(Z1).
作者姓名:宁连胜  侯子正  李丽庆  毛慧生  孙慧  赵文华  王文治  韩来声  赵宝林  张天泽
作者单位:天津市肿瘤研究所肿瘤医院,天津市肿瘤研究所肿瘤医院,天津市肿瘤研究所肿瘤医院,天津市肿瘤研究所肿瘤医院,天津市肿瘤研究所肿瘤医院,天津市肿瘤研究所肿瘤医院,天津和平区东兴市场卫生院,天津和平区东兴市场卫生院,天津河北区新开河卫生院,天津市肿瘤研究所肿瘤医院
摘    要:1982年,我们开始用正常小鼠肾包膜下移植方法(SRC)测定抗癌药物的敏感性。1986年应用临床治疗女性晚期乳腺癌。本文报告22例,年龄37~60岁,,除2例外,先前曾接受过放疗、化疗。22例中,单药治疗14例,联合用药8例。按国际通用标准评定疗效。结果,单药组及联合用药组的有效率分别为64%和87.5%,明显优于常用有效单药及联合化疗方案。

关 键 词:化疗晚期乳腺癌  肾包膜下移植方法(SRC)  药物敏感性

Chemotherapy of Advanced Breast Cancer under Guidance of Chemosensitivity Test (SRC Assay)
Ning Lian-Sheng,Hou Zi-Zheng et al Tianjin Cancer Hospital and Institute,Tianjin.Chemotherapy of Advanced Breast Cancer under Guidance of Chemosensitivity Test (SRC Assay)[J].Chinese Journal of Clinical Oncology,1991(Z1).
Authors:Ning Lian-Sheng  Hou Zi-Zheng Tianjin Cancer Hospital and Institute  Tianjin
Abstract:From Oct. 1986 to Dec. 1987, 24 patients with advanced breast cancer were treated by chemotherapy under the guidance of tumor response to chemotherapeutic agents with a 6-day subrenal capsule (SRC) assay. Among 22 evaluable cases, 14 cases were treated with single drug and 8 cases with combined agents. According to WHO's criterion for evaluating therapeutic effects, response rate of 64% was achieved in single drug group and 87.5% in combined agents group, which were evidently superior to chemotherapy given empirically.
Keywords:Chemotherapy Chemosensitivity Advanced breast cancer Subrenal capsule assay
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号